Woodline Partners’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-48,498
Closed -$4.78M – 1030
2025
Q3
$4.78M Sell
48,498
-47,000
-49% -$5.03M 0.02% 576
2025
Q2
$10.2M Sell
95,498
-22,000
-19% -$2.22M 0.05% 431
2025
Q1
$10.7M Buy
117,498
+147
+0.1% +$16.5K 0.07% 351
2024
Q4
$13.4M Sell
117,351
-434
-0.4% -$49.5K 0.09% 289
2024
Q3
$14M Buy
117,785
+5,247
+5% +$482K 0.12% 241
2024
Q2
$9.04M Buy
112,538
+57,803
+106% +$5.28M 0.09% 261
2024
Q1
$5.05M Sell
54,735
-72,825
-57% -$6.98M 0.05% 360
2023
Q4
$13.5M Hold
127,560
– – 0.15% 197
2023
Q3
$13.9M Buy
127,560
+81,760
+179% +$9.04M 0.16% 178
2023
Q2
$4.94M Buy
+45,800
New +$5.15M 0.06% 294

Other funds holding BNTX

Woodline Partners's BNTX Position: Q4 2025 in Review

Woodline Partners sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 48,498 shares — an estimated $4.78M sold.

Woodline Partners first reported a position in BNTX in Q2 2023 and held it in 10 quarters. The position peaked at $14M in Q3 2024. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • Woodline Partners reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • Woodline Partners sold 48,498 BioNTech shares in Q4 2025, an estimated $4.78M.
  • Woodline Partners first reported a position in BioNTech in Q2 2023 and held it in 10 quarters.
  • Woodline Partners's BioNTech position peaked at $14M in Q3 2024.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.